Article Details
Retrieved on: 2024-05-10 20:11:00
Tags for this article:
Click the tags to see associated articles and topics
Summary
The biotech company Applied DNA Sciences, Inc. reported a decrease in revenues due to less demand for COVID-19 testing, leading to a financial loss, impacting earnings assessments and valuations like EBITDA mentioned in fundamental analysis and corporate finance.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here